Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: ABL, Altimmune, Angion Biomedica, Astrazeneca, Atea, Bionet Asia, Biophytis, Brim, Codagenix, Curevac, Cynata, Ildong, I-Mab, LG Chem Life Sciences, Moderna, Neurophth, Nippon Shinyaku, Novavax, Pfizer, Pharmajet, RDIF, Rigel, Roche, Sinovac, Technovalia, VBI Vaccines.